Pune, India -- (SBWire) -- 04/30/2019 --Our latest research report entitled High-Flow Nasal Cannula Market (by component (air-oxygen blender, nasal cannula), application (bronchiectasis, acute respiratory failure, acute heart failure, carbon monoxide by end user), end-user (ambulatory care centers, long-term care centers)) provides complete and deep insights into the market dynamics and growth of High-Flow Nasal Cannula. Latest information on market risks, industry chain structure High-Flow Nasal Cannula cost structure and opportunities are offered in this report. The past, present and forecast market information will lead to investment feasibility by studying the essential High-Flow Nasal Cannula growth factors. The global high-flow nasal cannula market is projected to grow at a CAGR of 11% over the forecast period of 2018-2024.
For More Details Get Free Sample Pages of this Research Report@ https://www.infiniumglobalresearch.com/reports/sample-request/1811
Increasing Occurrences of Respiratory Disorders to Drive the Growth in High-flow Nasal Cannula market in the Next 6 Years
Factors such as increasing occurrences of respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, and the increasing popularity of heated humidified high-flow nasal cannulas are driving the growth of high flow nasal cannula market. Furthermore, investments in research and development programs by companies to come up with better products and more sophisticated technologies are also some of the factors boosting the growth of the market. In Addition, growing acceptance of oxygen therapy for home health care and advancement in developing new techniques is also fuelling the growth of high flow nasal cannula market.
North America Accounts the Maximum Market Share for High Flow Nasal Cannula Market
North America accounts for the maximum market share for high flow nasal cannula market followed by Europe. In North America region factors such as increasing in aged population, increasing patients suffering from respiratory diseases, low prices associated with the use of nasal cannula and factorable reimbursement policies are driving the growth of the high flow nasal cannula market. Additionally, the high-flow cannula market in the Asia Pacific is anticipated to increase on the favorable demographics, improved health care policies, and the fast-paced economic growth in this region.
Flexicare Limited has Acquired Medisize B.V.
November 2017, Flexicare Limited a leading UK headquartered manufacturer of medical devices, has acquired Medisize B.V. from an affiliate of Phillips-Medisize, LLC. Medisize B.V. is a manufacturer specializing in the supply and distribution of a wide range of respiratory and anesthesia products for critical care, neonatology, emergency, home care, and radiology. This acquisition of Medisize B.V. included operations in the Netherlands and subsidiaries in Germany and Italy.
Flexicare, a privately-owned manufacturer and supplier of medical devices, currently has a presence in more than 100 countries through distributors and subsidiaries in the United States, Middle East, India, China, Japan, Australia, and Malaysia.
Browse Detailed TOC, Description and Company Mentioned in this Premium Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-high-flow-nasal-cannula-market
Report Findings
1. Drivers
- Increasing Occurrences of Respiratory Disorders.
- Growing Acceptance of Oxygen Therapy for Home Health Care.
- Low Cost of High-Flow Nasal Cannula.
2. Restraints
- Low Rate of Adoption of Modern Healthcare Applications in Developing Economies Like Mea.
3. Opportunities
- Increase in Disposable Incomes and Rapid Growth in the Global Economy.
- Increasing Popularity of Modern Healthcare Products.
